News for Healthier Living

Immune Checkpoint Inhibitors 'High-Risk Yet Promising' for Cancer Patients Who Undergo Organ Transplant

A meta-analysis led by a researcher at Roswell Park Comprehensive Cancer Center has identified key factors that could improve outcomes for cancer patients treated with immune checkpoint inhibitors (ICIs) before or after a solid-organ transplant.

May 28, 2025


May 31 2025

May 30 2025

May 29 2025

May 28 2025

May 27 2025

May 26 2025

May 25 2025

May 24 2025

May 23 2025

May 22 2025

May 21 2025

May 20 2025

May 19 2025

May 18 2025

May 17 2025